Home > Result Summaries: Compounds > naratriptan > Result Summary for S2W40027

Result Summary for S2W40027

Result Summary

Protocol ID:	S2W40027
Clinical Study ID:	S2W40027
Official Title:	An open-label evaluation of the long-term safety of oral naratriptan 1mg twice daily as short-term prophylactic treatment for menstrually-associated migraine.
Phase:	Phase 4
Study Indications or Diseases:	Migraine Disorders
Generic Name:	naratriptan
Trade/Product Name:	amerge;naramig
Approved Drug Label:	http://www.gsk.com/products.html
Results Summary:	Click here to download result summary.
Citations:	Brandes J, Smith T, Powers C, et al. Long-term safety, tolerability and efficacy of naratriptan 1 mg BID in the prophylactic treatment of menstrually associated migraine. Headache 2002;42:451. Abstract S102. BrandesJL et al. Open label long term tolerability of naratriptan for short-term prevention of menstrually related migraine. Headache 2007;47:886-894.